Covaxin for kids: Bharat Biotech's partner requests approval for ages 2-18 in US

Bharat Biotech's US partner Ocugen has approached US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of Covaxin for children below 18

Related Keywords

Hindustan ,India General ,India ,United States ,New Delhi ,Delhi ,Bharat ,Shankar Musunuri ,Raches Ella ,Mansukh Mandaviya ,Ocugen ,Union Health ,Drug Administration ,World Health Organisation ,Serum Institute Covishield ,Pfizer ,Astrazeneca ,Technical Advisory Group ,Bharat Biotech ,Emergency Use Authorisation ,Emergency Use Listing ,Covaxin The ,Serum Institute ,Union Health Minister Mansukh Mandaviya ,Emergency Use Authorization ,Covid 19 ,Coronavirus ,Orld Health Organization Who ,Us ,Fda ,Approval ,Vaccine ,Covaxin ,